Charles Greg Guyer - Apr 28, 2023 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Technical Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Apr 28, 2023
Transactions value $
-$394,642
Form type
4
Date filed
5/8/2023, 04:20 PM
Previous filing
Mar 17, 2023
Next filing
Aug 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $16K +239 +0.48% $66.88 49.7K Apr 28, 2023 Direct F1
transaction BMRN Common Stock Tax liability -$411K -4.3K -8.66% $95.45 45.4K May 4, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the shares acquired by the reporting person on April 28, 2023, pursuant to the issuer's Employee Stock Purchase Plan.